From our observation that low-to-moderate MGMT immunoexpression correlates with early recurrence in non-functioning pituitary adenomas [21], the aim of the current study was to investigate the status of MGMT and MSH6 immunoexpression in a consecutive series of recurrent functioning macroadenomas. This evidence concerns the gene MGMT and pituitary gland adenoma.